A Tempe bioscience firm selling its DNA analysis kits to 25 countries worldwide is expanding into the education sector.Continue reading→

NuvOx Pharma, a clinical stage biotechnology company, announces that the FDA has allowed a Phase II clinical trial in 60 stroke patients to proceed to test NuvOx’s investigational drug product, dodecafluoropentane emulsion (DDFPe). Continue reading→

An Arizona State University team won $100,000 at the ASU Innovation Open on Friday to fund their business, which makes a device that relieves anxiety.Continue reading→

Amid the national opioid crisis, “Integrative Approaches to Pain Management” teaches health-care professionals non-pharmaceutical options.Continue reading→

Response is sign of potential loss of consciousnessContinue reading→

From her perch atop a ladder at the front of the room, AZBio president & CEO Joan Koerber-Walker shares AZBio’s key initiatives for 2018 and beyond with leaders from across our life science community. 

It was standing room only as researchers, entrepreneurs, business leaders, investors, philanthropists, and patient advocates joined the AZBio Board to kick of AZBio’s 15th year of supporting Arizona’s life science community.Continue reading→

Wildcat Play Hospital, STEM bus, robotic Legos thrilled kids at family-friendly eventContinue reading→

Dr. Felicia Goodrum and several of the nation’s most prominent human cytomegalovirus researchers have been awarded a five-year, $8.9 million collaborative grant to investigate how the virus lies dormant until it activates and poses life-threatening disease risk.Continue reading→